Literature DB >> 18930052

Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.

Nerea Huarte1, Maier Lorizate, Renate Kunert, José L Nieva.   

Abstract

The conserved, aromatic-rich membrane-proximal external region (MPER) of gp41 is functional in human immunodeficiency virus (HIV)-cell fusion by perturbing membrane integrity. Broadly-neutralizing 2F5 and 4E10 monoclonal antibodies (MAb-s) recognize amino- and carboxy-terminal epitope sequences within this domain, respectively. An MPER peptide overlapping 2F5 and 4E10 epitope sequences was capable of breaching the permeability barrier of lipid vesicles. Cholesterol and sphingomyelin raft-lipids, present at high quantities in the HIV-1 envelope, promoted exposure or occlusion of 4E10 epitope, respectively. Conversely, 2F5 epitope accessibility was affected to a lesser extent by these envelope lipids. These observations support the idea that MPER epitopes on membranes are segmented in terms of how they are affected by envelope lipids, which may have implications for MPER-based vaccine development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930052     DOI: 10.1016/j.febslet.2008.10.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

2.  Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1.

Authors:  Ashish K Solanki; Yogendra S Rathore; Maulik D Badmalia; Reema R Dhoke; Samir K Nath; Deepak Nihalani
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

3.  GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Authors:  Emma L Mohr; Jinhua Xiang; James H McLinden; Thomas M Kaufman; Qing Chang; David C Montefiori; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

4.  In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.

Authors:  Daniel P Leaman; Heather Kinkead; Michael B Zwick
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

5.  Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.

Authors:  S Moses Dennison; Shelley M Stewart; Kathryn C Stempel; Hua-Xin Liao; Barton F Haynes; S Munir Alam
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

6.  Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.

Authors:  Douglas S Watson; Francis C Szoka
Journal:  Vaccine       Date:  2009-06-09       Impact factor: 3.641

7.  Membrane topology analysis of HIV-1 envelope glycoprotein gp41.

Authors:  Shujun Liu; Naoyuki Kondo; Yufei Long; Dan Xiao; Aikichi Iwamoto; Zene Matsuda
Journal:  Retrovirology       Date:  2010-11-30       Impact factor: 4.602

8.  Function of membrane rafts in viral lifecycles and host cellular response.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  Biochem Res Int       Date:  2011-12-07

9.  Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.

Authors:  Gregory H Bird; Adriana Irimia; Gilad Ofek; Peter D Kwong; Ian A Wilson; Loren D Walensky
Journal:  Nat Struct Mol Biol       Date:  2014-11-24       Impact factor: 15.369

10.  Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.

Authors:  Luis M Molinos-Albert; Eneritz Bilbao; Luis Agulló; Silvia Marfil; Elisabet García; Maria Luisa Rodríguez de la Concepción; Nuria Izquierdo-Useros; Cristina Vilaplana; Jon A Nieto-Garai; F-Xabier Contreras; Martin Floor; Pere J Cardona; Javier Martinez-Picado; Bonaventura Clotet; Jordi Villà-Freixa; Maier Lorizate; Jorge Carrillo; Julià Blanco
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.